Find your path to Sheri
10 people in our graph can introduce you to Sheri.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Giuseppe Iademarco to introduce you to Sheri
You →Giuseppe · together at Dalian University of Technology →Sheri
Ask Jamie Chen to introduce you to Sheri
You →Jamie · 9 people · together at Dalian University of Technology →Sheri
Sign up to find every way you can get introduced to Sheri
- Your email: the people you already email who know Sheri
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Sheri
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Sheri Lin is Senior Executive Vice President at GeneLancet Biosciences, Inc., a company focused on the discovery of modified nucleosides, nucleotides, and phosphoramidites for research and biotechnological applications in genomics and nucleos(t)ide and oligonucleotide therapeutics. The company also develops chemical processes for nucleoside and nucleotide active pharmaceutical ingredients and designs nucleoside prodrugs for clinical development.
Executive at GeneLancet Biosciences
Intro paths
In turn, Sheri can intro founders to GeneLancet Biosciences's investors below.
GeneLancet Biosciences's investors · 2
Experience
- GeneLancet Biosciences, Inc.Senior Executive Vice Presidentcurrent2019 — presentDoylestown, Pennsylvania, United States
- APSIS Therapeutics, LTD.Vice presidentcurrent2010 — presentAlbany, New York Metropolitan Area
- APSIS Therapeutics, LTD.President & CEOcurrent2013 — presentAlbany, New York Metropolitan Area
Skills & more
From Sheri's professional profile.
Frequently asked questions
- Who is Sheri Lin?
- Sheri Lin is Senior Executive Vice President at GeneLancet Biosciences, Inc., a company focused on the discovery of modified nucleosides, nucleotides, and phosphoramidites for research and biotechnological applications in genomics and nucleos(t)ide and oligonucleotide therapeutics. The company also develops chemical processes for nucleoside and nucleotide active pharmaceutical ingredients and designs nucleoside prodrugs for clinical development.
- Where did Sheri Lin go to school?
- Sheri Lin studied at Brigham Young University (Master's degree, Chemical Engineering); Dalian University of Technology (Bachelor of Science (BS)).
Same school
Also attended Brigham Young University552
+ 546 more
Also attended Dalian University of Technology12
+ 6 more













